Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Kyotaro Ohta"'
Autor:
Hideki Yagi, Bisei Ohkawara, Hiroaki Nakashima, Kenyu Ito, Mikito Tsushima, Hisao Ishii, Kimitoshi Noto, Kyotaro Ohta, Akio Masuda, Shiro Imagama, Naoki Ishiguro, Kinji Ohno
Publikováno v:
PLoS ONE, Vol 11, Iss 1, p e0148470 (2016)
Externí odkaz:
https://doaj.org/article/4f17cbf85ee24d7baf8f9682239eaa78
Autor:
Hideki Yagi, Bisei Ohkawara, Hiroaki Nakashima, Kenyu Ito, Mikito Tsushima, Hisao Ishii, Kimitoshi Noto, Kyotaro Ohta, Akio Masuda, Shiro Imagama, Naoki Ishiguro, Kinji Ohno
Publikováno v:
PLoS ONE, Vol 10, Iss 11, p e0142786 (2015)
No clinically applicable drug is currently available to enhance neurite elongation after nerve injury. To identify a clinically applicable drug, we screened pre-approved drugs for neurite elongation in the motor neuron-like NSC34 cells. We found that
Externí odkaz:
https://doaj.org/article/9f081d4f6edd4696a839f43115e72ba9
Autor:
Hiroyuki Koshimizu, Taro Inoue, Kyotaro Ohta, Hiroaki Nakashima, Kinji Ohno, Bisei Ohkawara, Shiro Imagama, Hiroyuki Tomita, Naoki Ishiguro, Shunsuke Kanbara, Akio Masuda, Mikako Ito
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-13 (2020)
Scientific Reports
Scientific Reports
Cervical spondylotic myelopathy (CSM) is caused by chronic compression of the spinal cord and is the most common cause of myelopathy in adults. No drug is currently available to mitigate CSM. Herein, we made a rat model of CSM by epidurally implantin
Autor:
Taichi Tsuji, Toshiki Saito, Ayato Nohara, Ryoji Tauchi, Tetsuya Ohara, Noriaki Kawakami, Kyotaro Ohta, Yoshitaka Suzuki, Nobuyuki Hamajima, Shiro Imagama, Hiroaki Nakashima
Publikováno v:
Spine. 40(14)
STUDY DESIGN Retrospective case-controlled study. OBJECTIVE To investigate the incidence of adjacent segment degeneration (ASD) and the associated risk factors during a period of at least 10 years after posterior lumbar interbody fusion (PLIF). SUMMA
Autor:
Kimitoshi Noto, Kenyu Ito, Mikito Tsushima, Shiro Imagama, Hisao Ishii, Bisei Ohkawara, Kyotaro Ohta, Naoki Ishiguro, Kinji Ohno, Hiroaki Nakashima, Akio Masuda, Hideki Yagi
Publikováno v:
PLoS ONE
PLoS ONE, Vol 10, Iss 11, p e0142786 (2015)
PLoS ONE, Vol 10, Iss 11, p e0142786 (2015)
No clinically applicable drug is currently available to enhance neurite elongation after nerve injury. To identify a clinically applicable drug, we screened pre-approved drugs for neurite elongation in the motor neuron-like NSC34 cells. We found that
Autor:
Hiroaki Nakashima, Noriaki Kawakami, Taichi Tsuji, Tetsuya Ohara, Yoshitaka Suzuki, Toshiki Saito, Ayato Nohara, Ryoji Tauchi, Kyotaro Ohta, Nobuyuki Hamajima, Shiro Imagama
Publikováno v:
Spine (03622436); 7/15/2015, Vol. 40 Issue 14, pE831-E841, 11p